{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:39:26Z","timestamp":1790995166409,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T00:00:00Z","timestamp":1449619200000},"content-version":"vor","delay-in-days":5730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1046\/j.1523-1755.2000.00983.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:33:16Z","timestamp":1047461596000},"page":"1408-1411","source":"Crossref","is-referenced-by-count":171,"title":["Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology"],"prefix":"10.1016","volume":"57","author":[{"given":"John A.","family":"Delyani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.ph.55.030193.000555","article-title":"Aldosterone action","volume":"55","author":"Funder","year":"1993","journal-title":"Annu Rev Physiol"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.25.2.170","article-title":"Production of aldosterone in isolated rat blood vessels","volume":"25","author":"Takeda","year":"1995","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0020","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in the rat","volume":"273","author":"Silvestre","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0025","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1440-1681.1987.tb02422.x","article-title":"High affinity aldosterone binding sites (type I receptors) in rat heart","volume":"14","author":"Pearce","year":"1987","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lombes","year":"1992","journal-title":"Circ Res"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/26.7.671","article-title":"Reactive and reparative myocardial fibrosis in arterial hypertension in the rat","volume":"26","author":"Brilla","year":"1992","journal-title":"Cardiovasc Res"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0040","first-page":"E657","article-title":"Determinants of cardiac fibrosis in experimental hypermineralocorticoid states","volume":"269","author":"Young","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0045","doi-asserted-by":"crossref","unstructured":"Robert V, Ven Thiem N, Cheav SL, Mouas CB, Swynghedauw, Delcayre C: Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension 24:30-36.","DOI":"10.1161\/01.HYP.24.1.30"},{"issue":"20","key":"10.1046\/j.1523-1755.2000.00983.x_bb0050","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotension II receptor blockade and role in cardiac fibrosis","volume":"99","author":"Silvestre","year":"1999","journal-title":"Circulation"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0055","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.ATV.17.6.1152","article-title":"Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats","volume":"17","author":"Benetos","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajh\/4.8.680","article-title":"Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect","volume":"4","author":"Stier","year":"1991","journal-title":"Am J Hypertens"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0065","first-page":"S37","article-title":"Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats","volume":"11","author":"Stier","year":"1993","journal-title":"J Hypertens"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0075","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.HYP.32.6.965","article-title":"Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-I","volume":"32","author":"Brown","year":"1998","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1071-9164(96)80009-1","article-title":"Aldosterone escape during angiotensin converting enzyme inhibition therapy in chronic heart failure","volume":"2","author":"Struthers","year":"1996","journal-title":"J Cardiovasc Fail"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0085","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jps.2600610721","article-title":"Disposition of tritium-labeled spironolactone in the dog","volume":"61","author":"Sadee","year":"1972","journal-title":"J Pharm Sci"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0090","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/jps.2600610720","article-title":"Plasma levels of spironolactone levels in the dog","volume":"61","author":"Sadee","year":"1972","journal-title":"J Pharm Sci"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0095","first-page":"686","article-title":"Pharmacokinetics of spironolactone, canrenone, and canrenenoate-K in humans","volume":"185","author":"Sadee","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/jps.2600600510","article-title":"Pharmacokinetics and metabolic fate of potassium canrenoate in man","volume":"60","author":"Karim","year":"1971","journal-title":"J Pharm Sci"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cpt1976192158","article-title":"Disposition and metabolism","volume":"19","author":"Karim","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0110","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/jps.2600630817","article-title":"Comparison of spironolactone tablet dosage forms in healthy humans","volume":"63","author":"Hofman","year":"1974","journal-title":"J Pharm Sci"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0115","first-page":"650","article-title":"Three new epoxy-spironolactone derivatives: Characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1046\/j.1523-1755.2000.00983.x_bb0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815468899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815468899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T20:43:16Z","timestamp":1635540196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815468899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S0085253815468899"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00983.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}